Page last updated: 2024-09-03

tris(2-carboxyethyl)phosphine and oxidopamine

tris(2-carboxyethyl)phosphine has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(tris(2-carboxyethyl)phosphine)
Trials
(tris(2-carboxyethyl)phosphine)
Recent Studies (post-2010)
(tris(2-carboxyethyl)phosphine)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
26611458,63062,407

Protein Interaction Comparison

ProteinTaxonomytris(2-carboxyethyl)phosphine (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguiar, BW; Castro, MA; da Motta, LL; Dafre, AL; De Bastiani, MA; de Medeiros, LM; de Souza, LF; Freire, VN; Klamt, F; Londero, GF; Lopes, FM; Parsons, RB; Pfaffenseller, B; Schönhofen, P; Vargas, DM; Zanatta, G1

Other Studies

1 other study(ies) available for tris(2-carboxyethyl)phosphine and oxidopamine

ArticleYear
RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Neurotoxicity research, 2017, Volume: 31, Issue:4

    Topics: Antioxidants; Cell Death; Cell Differentiation; Cells, Cultured; Dithiothreitol; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Humans; Hydrogen Peroxide; Oxidation-Reduction; Oxidopamine; Phosphines; Tretinoin

2017